Subdural empyema medical therapy

Jump to navigation Jump to search

Empyema Main Page

Subdural empyema Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Subdural empyema from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Lumbar Puncture

X Ray

CT

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Subdural empyema medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Subdural empyema medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Subdural empyema medical therapy

CDC on Subdural empyema medical therapy

Subdural empyema medical therapy in the news

Blogs on Subdural empyema medical therapy

Directions to Hospitals Treating Subdural empyema

Risk calculators and risk factors for Subdural empyema medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; João André Alves Silva, M.D. [2]

Overview

Subdural empyema, also referred to as subdural abscess, pachymeningitis interna and circumscript meningitis, is a life-threatening infection, first reported in literature approximately 100 years ago.[1] It consists of a localised collection of purulent material, usually unilateral, between the dura mater and thearachnoid mater. It accounts for about 15-22% of the reported focal intracranial infections. The empyema may develop intracranially (about 95%) or in the spinal canal (about 5%), and in both cases, it constitutes a medical and neurosurgical emergency.[2] The intracranial type tends to behave like an expanding mass, causing clinical symptoms, such as fever, lethargy, headache and neurological deficits. These, result from the extrinsic compression of the brain, caused not only from the inflammatory mass, but also from the inflammation of the brain and meninges. Because thesubdural space has no septations, except in areas where arachnoid granulations attach to the dura mater, the subdural empyema tends to spread quickly, until it finds those boundaries. In children, subdural empyema most often happens as a complication of meningitis, while in adults it usually occurs as a complication of sinusitis, otitis media, mastoiditis, trauma or as a complication of neurological procedures.[1] The most common pathogens in the intracranial type are anaerobic and microaerophilic streptococci, however others like Escherichia coli and Bacteroides may be present simultaneously. Spinal subdural empyemas, on the other hand, are almost always caused bystreptococci or by staphylococcus aureus.[2] The classic clinical syndrome includes acute fever, that rapidly progresses into neurological deterioration, which if left untreated will eventually lead to a comaand death.[1] The diagnostic procedure of choice is the MRI with gadolinium enhancement. Since the clinical symptoms might be mild and unspecific initially, the rapid diagnosis and treatment are crucial. The sooner the proper treatment is initiated, the better the recovery will be. The treatment, for almost all causes, requires prompt surgical drainage and antibiotic therapy.[2] With treatment, resolution of the empyema occurs from the dural side, and, if it is complete, a thickened dura may be the only residual finding.

Medical Therapy

Complications

Follow-Up and Prognosis

Prognostic factors associated with Subdural Empyema

[1]

Unfavorable prognostic factors

  ▸  Presenting with encephalopathy or coma

  ▸  Younger than 10 or elderly

  ▸  Late start of antibiotics

  ▸  Sterile cultures

Favourable prognostic factors

  ▸  Craniotomy instead of burr holes as surgical procedure

  ▸  Isolation of Aerobic streptococci

References

  1. 1.0 1.1 1.2 1.3 Agrawal, Amit; Timothy, Jake; Pandit, Lekha; Shetty, Lathika; Shetty, J.P. (2007). "A Review of Subdural Empyema and Its Management". Infectious Diseases in Clinical Practice. 15 (3): 149–153. doi:10.1097/01.idc.0000269905.67284.c7. ISSN 1056-9103.
  2. 2.0 2.1 2.2 Greenlee JE (2003). "Subdural Empyema". Curr Treat Options Neurol. 5 (1): 13–22. PMID 12521560.

Template:WH Template:WS